Two other GLP-1 receptor agonist products -- dulaglutide (Trulicity) and liraglutide (Victoza, Saxenda) -- still remain in ...

(WRDW/WAGT) - Drug shortages in the United States are at ... The retired veteran says he’s been able to manage the disease using Trulicity, a drug that’s become popular as an alternative ...

Mounjaro (tirzepatide) led to greater weight loss and better glucose control than high doses of Trulicity (dulaglutide), according to a study published April 4 in Annals of Internal Medicine.

At present, the only GLP-1 products on the shortage list are dulaglutide, sold by Eli Lilly under the Trulicity brand, and liraglutide which Novo Nordisk sells as Victoza. Both are FDA-approved to ...

Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage cover various diabetes-related costs, including Trulicity. Out-of-pocket costs may apply.

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

Ozempic (semaglutide) and Trulicity (dulaglutide) are brand-name subcutaneous injections. They’re both prescribed for adults with type 2 diabetes who may or may not have certain cardiovascular ...